drug

nintedanib dry

1 story · latest Jul 1, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Mannkind Corporation

Timeline

MannKind registers Phase 2 trial of inhaled nintedanib for pulmonary fibrosis

Jul 1Trial updateMannkind Corporation nintedanib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.